BNP Paribas Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $94.2M | Sell |
3,912,107
-2,679,161
| -41% | -$70.1M | 0.09% | 201 |
|
|
2026
Q1 | $185M | Buy |
6,591,268
+717,845
| +12% | +$19.1M | 0.21% | 96 |
|
|
2025
Q4 | $146M | Sell |
5,873,423
-8,055
| -0.1% | -$203K | 0.17% | 115 |
|
|
2025
Q3 | $149M | Sell |
5,881,478
-1,680,468
| -22% | -$41.5M | 0.39% | 47 |
|
|
2025
Q2 | $183M | Buy |
7,561,946
+3,472,240
| +85% | +$81M | 0.45% | 37 |
|
|
2025
Q1 | $104M | Sell |
4,089,706
-1,432,093
| -26% | -$37.5M | 0.28% | 87 |
|
|
2024
Q4 | $146M | Sell |
5,521,799
-1,794,606
| -25% | -$48.7M | 0.36% | 61 |
|
|
2024
Q3 | $212M | Buy |
7,316,405
+4,546,809
| +164% | +$133M | 0.52% | 33 |
|
|
2024
Q2 | $77.5M | Buy |
2,769,596
+1,877,957
| +211% | +$51.7M | 0.2% | 114 |
|
|
2024
Q1 | $24.7M | Sell |
891,639
-1,625,461
| -65% | -$45.1M | 0.07% | 276 |
|
|
2023
Q4 | $72.5M | Sell |
2,517,100
-751,606
| -23% | -$22.7M | 0.2% | 131 |
|
|
2023
Q3 | $108M | Buy |
3,268,706
+1,567,046
| +92% | +$55.4M | 0.33% | 69 |
|
|
2023
Q2 | $62.4M | Sell |
1,701,660
-771,185
| -31% | -$30M | 0.19% | 127 |
|
|
2023
Q1 | $101M | Sell |
2,472,845
-88,016
| -3% | -$3.8M | 0.35% | 61 |
|
|
2022
Q4 | $131M | Sell |
2,560,861
-346,909
| -12% | -$16.6M | 0.47% | 46 |
|
|
2022
Q3 | $127M | Buy |
2,907,770
+388,298
| +15% | +$18.9M | 0.5% | 37 |
|
|
2022
Q2 | $132M | Sell |
2,519,472
-486,441
| -16% | -$24.8M | 0.5% | 37 |
|
|
2022
Q1 | $156M | Buy |
3,005,913
+483,989
| +19% | +$25.1M | 0.54% | 31 |
|
|
2021
Q4 | $149M | Buy |
2,521,924
+1,075,711
| +74% | +$53.3M | 0.5% | 37 |
|
|
2021
Q3 | $62.2M | Sell |
1,446,213
-824,954
| -36% | -$36.5M | 0.23% | 104 |
|
|
2021
Q2 | $88.9M | Buy |
2,271,167
+505,153
| +29% | +$19.6M | 0.32% | 65 |
|
|
2021
Q1 | $64M | Sell |
1,766,014
-225,808
| -11% | -$8.02M | 0.26% | 87 |
|
|
2020
Q4 | $73.3M | Sell |
1,991,822
-184,626
| -8% | -$6.77M | 0.34% | 68 |
|
|
2020
Q3 | $75.8M | Buy |
2,176,448
+937,397
| +76% | +$32.9M | 0.43% | 50 |
|
|
2020
Q2 | $38.4M | Buy |
1,239,051
+85,794
| +7% | +$2.91M | 0.26% | 104 |
|
|
2020
Q1 | $35.7M | Sell |
1,153,257
-294,380
| -20% | -$10M | 0.3% | 92 |
|
|
2019
Q4 | $53.8M | Sell |
1,447,637
-358,144
| -20% | -$12.8M | 0.37% | 61 |
|
|
2019
Q3 | $61.6M | Buy |
1,805,781
+402,215
| +29% | +$14.6M | 0.47% | 40 |
|
|
2019
Q2 | $57.7M | Buy |
1,403,566
+153,851
| +12% | +$6.11M | 0.47% | 41 |
|
|
2019
Q1 | $50.4M | Buy |
1,249,715
+33,840
| +3% | +$1.36M | 0.42% | 48 |
|
|
2018
Q4 | $49.6M | Sell |
1,215,875
-83,594
| -6% | -$3.47M | 0.46% | 43 |
|
|
2018
Q3 | $54.3M | Buy |
1,299,469
+185,583
| +17% | +$7.14M | 0.42% | 51 |
|
|
2018
Q2 | $38.3M | Buy |
1,113,886
+90,568
| +9% | +$3.1M | 0.32% | 75 |
|
|
2018
Q1 | $34.5M | Sell |
1,023,318
-84,432
| -8% | -$2.9M | 0.29% | 87 |
|
|
2017
Q4 | $38.1M | Buy |
1,107,750
+186,378
| +20% | +$6.36M | 0.32% | 70 |
|
|
2017
Q3 | $31.2M | Sell |
921,372
-42,916
| -4% | -$1.38M | 0.26% | 84 |
|
|
2017
Q2 | $30.7M | Sell |
964,288
-142,496
| -13% | -$4.49M | 0.27% | 84 |
|
|
2017
Q1 | $35.9M | Sell |
1,106,784
-58,014
| -5% | -$1.83M | 0.33% | 67 |
|
|
2016
Q4 | $35.9M | Sell |
1,164,798
-560,787
| -32% | -$17.1M | 0.34% | 66 |
|
|
2016
Q3 | $55.5M | Sell |
1,725,585
-89,722
| -5% | -$3M | 0.47% | 39 |
|
|
2016
Q2 | $60.6M | Buy |
1,815,307
+19,004
| +1% | +$607K | 0.51% | 37 |
|
|
2016
Q1 | $50.5M | Buy |
1,796,303
+211,318
| +13% | +$6.04M | 0.43% | 48 |
|
|
2015
Q4 | $48.5M | Buy |
1,584,985
+148,560
| +10% | +$4.67M | 0.41% | 52 |
|
|
2015
Q3 | $42.8M | Buy |
1,436,425
+127,041
| +10% | +$4.07M | 0.38% | 52 |
|
|
2015
Q2 | $41.7M | Sell |
1,309,384
-631,414
| -33% | -$20.6M | 0.34% | 67 |
|
|
2015
Q1 | $64.1M | Sell |
1,940,798
-686,705
| -26% | -$21.8M | 0.49% | 38 |
|
|
2014
Q4 | $77.7M | Sell |
2,627,503
-181,012
| -6% | -$5.19M | 0.63% | 23 |
|
|
2014
Q3 | $78.8M | Buy |
2,808,515
+23,821
| +0.9% | +$669K | 0.64% | 25 |
|
|
2014
Q2 | $78.4M | Sell |
2,784,694
-635,686
| -19% | -$18.1M | 0.61% | 25 |
|
|
2014
Q1 | $104M | Buy |
3,420,380
+201,522
| +6% | +$6.01M | 0.79% | 16 |
|
|
2013
Q4 | $93.5M | Sell |
3,218,858
-274,226
| -8% | -$7.98M | 0.7% | 23 |
|
|
2013
Q3 | $95.2M | Sell |
3,493,084
-1,530,584
| -30% | -$41.6M | 0.72% | 21 |
|
|
2013
Q2 | $134M | Buy |
+5,023,668
| New | +$139M | 0.99% | 8 |
|
Other funds holding PFE
BNP Paribas Asset Management's PFE Position: Q2 2026 in Review
BNP Paribas Asset Management reduced its Pfizer (PFE) stake by 41% in Q2 2026, selling an estimated $70.1M and leaving 3,912,107 shares worth $94.2M. The position accounts for 0.09% of the portfolio, ranked #201.
BNP Paribas Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $212M in Q3 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- BNP Paribas Asset Management held 3,912,107 shares of Pfizer worth $94.2M as of Q2 2026.
- BNP Paribas Asset Management sold 2,679,161 Pfizer shares in Q2 2026, an estimated $70.1M.
- Pfizer made up 0.09% of BNP Paribas Asset Management's portfolio in Q2 2026, its #201 holding.
- BNP Paribas Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- BNP Paribas Asset Management's Pfizer position peaked at $212M in Q3 2024.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.